Navigation Menu

Clinical Trial External Search


Children (age < 18 years)
Adults (age >= 18 years)

Researcher Profile

Researcher Display

Elizabeth Finch, MD

Elizabeth Finch, MD

Assistant Professor, Department of Pediatrics
Division of Hematology and Oncology
Scientific Program:Next-Generation Therapies
EVF5234@psu.edu

Research Interests

  • Therapeutics
  • Pediatrics
  • Glioma
  • Neoplasms
  • Primitive Neuroectodermal Tumors
  • Immunotherapy
  • Education
  • Histones
  • National Cancer Institute (U.S.)
  • Central Nervous System Neoplasms
  • Vemurafenib
  • Mutation

Recent Publications

2024

Fisher, JE, Mulieri, K, Finch, E & Ericson, JE 2024, 'Use of Maribavir for Multidrug Resistant Cytomegaloviremia in a Pediatric Oncology Patient', Journal of pediatric hematology/oncology, vol. 46, no. 3, pp. E244-E247. https://doi.org/10.1097/MPH.0000000000002841

2022

Bailey, D, Mau, C, Toepke, C, Finch, E & Rizk, E 2022, 'Extracranial medulloepithelioma: a review of the literature', Child's Nervous System, vol. 38, no. 7, pp. 1259-1266. https://doi.org/10.1007/s00381-022-05525-4

2020

Finch, EA, Duke, E, Hwang, EI & Packer, RJ 2020, 'Immunotherapy Approaches for Pediatric CNS Tumors and Associated Neurotoxicity', Pediatric Neurology, vol. 107, pp. 7-15. https://doi.org/10.1016/j.pediatrneurol.2020.01.004
Theeler, BJ, Dalal, Y, Monje, M, Shilatifard, A, Suvà, ML, Aboud, O, Camphausen, K, Cordova, C, Finch, E, Heiss, JD, Packer, RJ, Romo, CG, Aldape, K, Penas-Prado, M, Armstrong, T & Gilbert, MR 2020, 'NCI-CONNECT: Comprehensive Oncology Network Evaluating Rare CNS Tumors - Histone Mutated Midline Glioma Workshop Proceedings', Neuro-Oncology Advances, vol. 2, no. 1, vdaa007. https://doi.org/10.1093/noajnl/vdaa007